These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 24651720)

  • 21. [TIM-3/galectin-9 is involved in negative regulation of T cells in patients with chronic lymphocytic leukemia].
    Xierenguli A; Zeng X; Pang N; Zhagn R; Ma J; Zhao Y; Qu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Nov; 36(11):1021-1025. PubMed ID: 33210597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9.
    Gleason MK; Lenvik TR; McCullar V; Felices M; O'Brien MS; Cooley SA; Verneris MR; Cichocki F; Holman CJ; Panoskaltsis-Mortari A; Niki T; Hirashima M; Blazar BR; Miller JS
    Blood; 2012 Mar; 119(13):3064-72. PubMed ID: 22323453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Galectin-9 Alleviates LPS-Induced Preeclampsia-Like Impairment in Rats via Switching Decidual Macrophage Polarization to M2 Subtype.
    Li ZH; Wang LL; Liu H; Muyayalo KP; Huang XB; Mor G; Liao AH
    Front Immunol; 2018; 9():3142. PubMed ID: 30687334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysregulated Tim-3 expression on natural killer cells is associated with increased Galectin-9 levels in HIV-1 infection.
    Jost S; Moreno-Nieves UY; Garcia-Beltran WF; Rands K; Reardon J; Toth I; Piechocka-Trocha A; Altfeld M; Addo MM
    Retrovirology; 2013 Jul; 10():74. PubMed ID: 23866914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The immunological effect of Galectin-9/TIM-3 pathway after low dose Mifepristone treatment in mice at 14.5 day of pregnancy.
    Lajko A; Meggyes M; Polgar B; Szereday L
    PLoS One; 2018; 13(3):e0194870. PubMed ID: 29566059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of Tim-3/Galectin-9 pathway and CD8+T cells and related factors in patients with cystic echinococcosis.
    Zhao H; Ma Y; Tian F; Li B; Xiao N; Mo X; Aibibula M; Min H; Cai X; Zhang T; Ma X
    Exp Parasitol; 2023 Nov; 254():108623. PubMed ID: 37793539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C.
    Szereday L; Meggyes M; Berki T; Miseta A; Farkas N; Gervain J; Par A; Par G
    Clin Exp Med; 2020 May; 20(2):219-230. PubMed ID: 32108916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of the Tim-3/Gal-9 pathway and correlation with the development of preeclampsia.
    Hao H; He M; Li J; Zhou Y; Dang J; Li F; Yang M; Deng D
    Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():85-91. PubMed ID: 26342682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased Tim-3 expression in peripheral NK cells predicts a poorer prognosis and Tim-3 blockade improves NK cell-mediated cytotoxicity in human lung adenocarcinoma.
    Xu L; Huang Y; Tan L; Yu W; Chen D; Lu C; He J; Wu G; Liu X; Zhang Y
    Int Immunopharmacol; 2015 Dec; 29(2):635-641. PubMed ID: 26428847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased Tim-3 expression on peripheral T lymphocyte subsets and association with higher disease activity in systemic lupus erythematosus.
    Song LJ; Wang X; Wang XP; Li D; Ding F; Liu HX; Yu X; Li XF; Shu Q
    Diagn Pathol; 2015 Jun; 10():71. PubMed ID: 26076826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction between Galectin-9/TIM-3 pathway and follicular helper CD4
    Zhuo Y; Zhang YF; Wu HJ; Qin L; Wang YP; Liu AM; Wang XH
    Biomed Pharmacother; 2017 Oct; 94():386-393. PubMed ID: 28772217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression and significance of Tim-3 on peripheral blood monocytes in patients with chronic hepatitis B].
    Gao X; Li C; Pan X; Li L; Fu J; Yao W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jul; 29(7):739-43. PubMed ID: 23837986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activated Galectin-9/Tim3 promotes Treg and suppresses Th1 effector function in chronic lymphocytic leukemia.
    Pang N; Alimu X; Chen R; Muhashi M; Ma J; Chen G; Zhao F; Wang L; Qu J; Ding J
    FASEB J; 2021 Jul; 35(7):e21556. PubMed ID: 34137463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts.
    Wang F; He W; Yuan J; Wu K; Zhou H; Zhang W; Chen ZK
    Transpl Immunol; 2008 Apr; 19(1):12-9. PubMed ID: 18346632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Galectin-9 contributes to the pathogenesis of atopic dermatitis
    Su W; Zhang J; Yang S; Tang M; Shen Y; Liu C; Ji J; Maurer M; Jiao Q
    Front Immunol; 2022; 13():952338. PubMed ID: 35967337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated Galectin-9 Suppresses Th1 Effector Function and Induces Apoptosis of Activated CD4
    Yang S; Wang J; Chen F; Liu G; Weng Z; Chen J
    Inflammation; 2017 Jun; 40(3):1062-1071. PubMed ID: 28393295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TIM-3 does not act as a receptor for galectin-9.
    Leitner J; Rieger A; Pickl WF; Zlabinger G; Grabmeier-Pfistershammer K; Steinberger P
    PLoS Pathog; 2013 Mar; 9(3):e1003253. PubMed ID: 23555261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative Tim‑3 expression on peripheral NK cells is correlated with pathologic TNM staging in colorectal cancer.
    Wang Y; Sun J; Gao W; Song B; Shao Q; Zhao L; Zhang Y; Wang Q; Zhang Y; Qu X
    Mol Med Rep; 2017 Jun; 15(6):3810-3818. PubMed ID: 28440449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B.
    Ju Y; Hou N; Meng J; Wang X; Zhang X; Zhao D; Liu Y; Zhu F; Zhang L; Sun W; Liang X; Gao L; Ma C
    J Hepatol; 2010 Mar; 52(3):322-9. PubMed ID: 20133006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of Tim-3/Galectin-9 pathway in T-cell function and prognosis of patients with human papilloma virus-associated cervical carcinoma.
    Chen Z; Dong D; Zhu Y; Pang N; Ding J
    FASEB J; 2021 Mar; 35(3):e21401. PubMed ID: 33559190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.